APA (7th ed.) Citation

MM, R., DN, H., D, P., SS, S., RS, F., S, Z., . . . ME, S. (2023). Trials for Slowly Progressive Neurogenetic Diseases Need Surrogate Endpoints. Annals of neurology, 93(5), 906. https://doi.org/10.1002/ana.26633

Chicago Style (17th ed.) Citation

MM, Reilly, Herrmann DN, Pareyson D, Scherer SS, Finkel RS, Züchner S, Burns J, and Shy ME. "Trials for Slowly Progressive Neurogenetic Diseases Need Surrogate Endpoints." Annals of Neurology 93, no. 5 (2023): 906. https://doi.org/10.1002/ana.26633.

MLA (9th ed.) Citation

MM, Reilly, et al. "Trials for Slowly Progressive Neurogenetic Diseases Need Surrogate Endpoints." Annals of Neurology, vol. 93, no. 5, 2023, p. 906, https://doi.org/10.1002/ana.26633.